@ruth_capital@BRICSinfo All jokes aside ever since the earnings dump, it’s held up incredibly well compared to the rest of the MAG7. Good sign to see for whenever the market eventually turns
@SixSigmaCapital Everyone knows it’s cheap, the problem is the market doesn’t care rn. I’ve been hesitant to add to my position because i do believe we see sub 500. Part of me wants it to just get to the 200 MA around 438 so all the bad news can be priced in and i can double my position
@ManzTrades With the tech sector P/E down to tarrif lows, what’s your current take on the mag7 and are they are attractive to you or not yet? I still feel like we get a face ripping tech rally this year as of now
@amitisinvesting It’s so cheap but haven’t added to my position yet. Gotta let the dust settle plus potential US escalation over the weekend could send this even lower.
@aleabitoreddit The sell of has nothing to do with the war. The charts were already breaking down prior. I’m long Mag7 and think the recovery will be a faceripper, it’s just going to take a lot more than the war ending. Market wants to see justified capex spend especially from $META
@MichaelPBento@market_sleuth We haven’t reached peak euphoria anywhere near the dot com bubble for the market to have a crash that significant in comparison yet. NASDAQ went up 100% in the final 9 months leading up to that crash
@PurpleDrink_LLC I think it’s unfortunate timing for the software sector because it really did start to feel like some names were finally carving out a bottom or very close to since the start of the sector massacre
The zero-interest rate era has, in many cases, changed the mindset of stock investors for the worse. For years, Big Tech companies didn't know what to do with their accumulated earnings and have stockpiled their balance sheets with cash or/and initiated big buyback programs and dividends.
The reason a company pays a dividend or does a buyback is that it signals that internally, they don't see any projects worth the ROI to invest in, and instead choose to return capital to shareholders.
While these periods in the short-term might be enticing for many investor they signal lower growth potential over a longer period of time.
But now we are finally in a period where Big Tech companies are investing large amounts in CapEx, which, in turn, reduces or even lowers their FCF to zero, as they are signaling with their actions and words that they see big investment opportunities (future growth).
A rational investor would be excited about such times, as it signals accelerating long-term growth for these companies, but on the market, the opposite is happening.
IMO, there are two reasons for this. One is the irrational reaction that has become ingrained in many investors' minds over the past years, as they have become accustomed to Big Tech doing massive buybacks and dividends, giving them a sense of less change and more predictable short-term results, even if it is at the expense of higher long-term growth.
The second reason, which is a rational one in essence, is that a long-term investor would not like such an act if they believe these investments won't yield good returns.
I believe both reasons have taken over the sentiment in the market, and while I can't rationally relate to the first reason, when it comes to the second reason of fearing what the ROI will be on these CapEx, I believe investors are overly concerned.
These companies are already showing us that their "2023 AI CapEx" investments are turning into really good ROIs. You can look at the accelerating revenue of $META or $GOOGL's GCP margin, which jumped to 30% from 17% despite AI workloads being the biggest driver of growth.
On top of that, almost anyone who has seriously used this new technology in any field has at some point been amazed by its effects. In one sense, the market expects SaaS to die as everyone vibecodes and uses live-generated SaaS tools. At the same time, the market also believes the investments needed to generate these tokens for this usage are unnecessary and will result in poor ROI.
For a long-term investor, this sentiment, on top of the period of accelerating growth and efficiency that will come from this new technology, is a gift, not a curse.
The investors able to adapt to this new shift in mindset away from the ZIRP thinking will be the ones who will benefit the most.
@AdamSliverTrade Agree with a lot of this. My early lean is a pullback sometime in 1Q26 and then the trump admin will run the market hot all the way into midterms. OpenAI and Anduril IPO could signal a market top is near
$SPY Closed out my last runner at $1.96 earlier. My biggest % gainer ever on a trade. Always learning from the best @Hugh_Henne@manztrades@MrZackMorris and applying that knowledge to these trades i take
$SPY 15 minute close above Hugh’s 382.47 key level and I scalped 0 DTE $385 calls. You don’t get enough love for your levels thank you for sharing everyday @Hugh_Henne 🐐
My ultimate $CNTX find
🔹 In 2020, Menarini acquired Stemline therapeutics (STML) for $677M
🔸STML ran over 200% after news
🔹 From website, “Menarini is also committed to oncology”
💣 my thoughts💣
If good data is presented between the 2, $CNTX is on buyout watch
$CNTX Btw you pussstaches. I told you I liked CYCC 1.10s and look it now. You will feel so stupid when $CNTX is $5. We’re all going to laugh at you and f your girl
My ultimate $CNTX find
🔹 In 2020, Menarini acquired Stemline therapeutics (STML) for $677M
🔸STML ran over 200% after news
🔹 From website, “Menarini is also committed to oncology”
💣 my thoughts💣
If good data is presented between the 2, $CNTX is on buyout watch
$CNTX
▫️ 4 PR’s coming up this year; 3 of them regarding data
▫️NEW Menarini collab: ONA-XR + Elacestrant
➖ Elacestrant potential to be the 1st❕FDA approved oral SERD
➖Menarini was the leading italian pharm company that generated $3.9B euros in revenue🔥
@MrZackMorris
$CNTX overview on their product ONA-XR data expected mid ‘22
🔘Being evaluated in 4(!) phase 2 trials and 2 phase 0 trials
•🔘ONA-XR the only known full PR antagonist👀
🔘No current approved therapies that target (PR+) cancers so ONA-XR would be the 1st
@MrZackMorris